@article{95427,
  author = {Hoesly P and Cappel M and Hoesly F and Sluzevich J and Tolaymat L and Keeling J},
  title = {Leprosy as a Diagnostic Challenge in the United States.},
  abstract = {<p>A 63-year-old woman from Central Florida presented to an outside clinic with a 2-year history of a progressive, asymptomatic cutaneous eruption and arthralgias. Her past medical history was significant for reported seronegative rheumatoid arthritis, for which adalimumab, methotrexate, and low-dose prednisone therapy were initiated 5 years prior. The skin eruption occurred shortly after a 4-week hospitalization during which these medications were withheld. At her initial outside evaluation, a biopsy was performed and interpreted as subacute cutaneous lupus erythematosus (SCLE). She was treated with hydroxychloroquine without improvement. A repeat biopsy was reported as consistent with interstitial granulomatous dermatitis (IGD). There was no improvement with potent topical corticosteroids.</p>},
  year = {2021},
  journal = {Skinmed},
  volume = {19},
  pages = {137-141},
  month = {01/2021},
  issn = {1751-7125},
  language = {eng},
}